Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Acetate is a driver of quiescence in ovarian cancer

ABSTRACT: Acetate is a driver of quiescence in ovarian cancer

PROVIDER: PRJNA1129463 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Acetate is a driver of quiescence in ovarian cancer

Project description:While prior work in muscle cells indicates that metabolic reprogramming is associated with quiescence, whether metabolic changes occur in cancer to drive quiescence is unclear. Using a multi-omics approach, we found that the metabolic enzyme ACSS2 is both highly upregulated in quiescent cells and required for their survival. ACSS2 converts acetate into acetyl-CoA, and we confirmed increased acetate-derived acetyl-CoA in quiescent cells, demonstrating increased ACSS2 activity. Interestingly, supplementing cells with acetate alone was sufficient to induce a reversible quiescent cell cycle exit.

2024-10-16 | GSE271035 | GEO

Serum starvation induces quiescence in ovarian cancer

2024-10-16 | GSE271357 | GEO

Serum starvation induces quiescence in ovarian cancer

Project description:Serum starvation induces quiescence in ovarian cancer

| PRJNA1130989 | ENA

MNRR1 is a driver of ovarian cancer progression

Project description:MNRR1 is a driver of ovarian cancer progression

| PRJNA903221 | ENA

Microarray analysis of MCF7 cells treated with NSC 59687 (Oxyphenisatin Acetate)

2013-03-13 | GSE45046 | GEO

MNRR1 is a driver of ovarian cancer progression

Project description:This study was conducted to investigate the role of MNRR1 in regulating the extracellular matrix and focal adhesion modulating ovarian cancer metastasis

2023-01-15 | GSE218364 | GEO

IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer

Project description:IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer

| PRJNA622728 | ENA

Ovarian serous cancer

Project description:Ovarian serous cancer

| PRJNA117359 | ENA

Microarray analysis of MCF7 cells treated with NSC 59687 (Oxyphenisatin Acetate)

Project description:NSC 59687 (oxyphenisatin acetate) is a novel anti-cancer agent with selectivity for breast and ovarian cell lines To elucidate the transcripts differentially regulated following treatment with Oxyphenisatin acetate (NSC 59687) MCF7 cells were treated with 10 microM NSC 59687 for 24 hours followed by RNA extraction, cDNA synthesis and microarray analysis using Affymetrix huU133 plus 2.0 arrays

2013-03-13 | E-GEOD-45046 | biostudies-arrayexpress

Matrix Gla Protein acts as a driver of stemness and tumor initiation in ovarian cancer

Project description:Matrix Gla Protein acts as a driver of stemness and tumor initiation in ovarian cancer

| PRJNA893692 | ENA